Search - tctmd.com

Displaying 21 - 40 of 43

Sort: Relevancy | Date

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

Presenter: Saibal Kar

September 15, 2014

Presentation TCT 2014

Case #2: Transseptal Puncture for Left Atrial Appendage Closure

Presenter: Samir R. Kapadia, Saibal Kar, Ramon Quesada, Brian K. Whisenant

September 15, 2014

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

Presentation TCT 2014

LARIAT Nightmare Case and Teaching Moment #2: Failure to Occlude

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Saibal Kar

September 13, 2014

Presentation LAA 2014

Imaging Guidance of the LAA Closure Procedure: From Trans-Septal Puncture to Device Sizing and Placement

Presenter: Saibal Kar

July 19, 2014

Presentation LAA 2014

Atrial finbillation and LAA Closure in the MitraClip Patient

Presenter: Saibal Kar

July 19, 2014

Presentation LAA 2014

The case of Watchman Approval

Presenter: Saibal Kar

July 18, 2014

Presentation LAA 2014

Device-based LAA Closure 2014: From Indications to Worldwide Practice

Presenter: Saibal Kar

July 17, 2014

Presentation LAA 2014

LAA Closure: The Device, Attribute and Basic Technique- The Watchman Device -

Presenter: Saibal Kar

July 17, 2014

Presentation TCT 2013

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Presenter: Saibal Kar

October 28, 2013

Presentation TCT 2013

Watchman

Presenter: Saibal Kar

October 27, 2013

Presentation TCT 2013

Deep Dive of the Watchman Data: PROTECT AF, CAP AND PREVAIL Safety Issues

Presenter: Saibal Kar

October 27, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

Presentation TVT 2013

Keynote Address: Interpreting PROTECT AF, CAP, and PREVAIL: Who Is the Ideal Patient?

Presenter: Saibal Kar

June 15, 2013

Presentation TVT 2013

Basic Echo Imaging of the LAA with Fluoroscopic Correlation

Presenter: Saibal Kar

June 15, 2013

Presentation TCT 2012

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

Prevail Study: Design and Current Status

Presenter: Saibal Kar

October 23, 2012

Advertisement

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

Case #2: Transseptal Puncture for Left Atrial Appendage Closure

Can LAA Closure Become the New Standard for Stroke Prevention?

LARIAT Nightmare Case and Teaching Moment #2: Failure to Occlude

Imaging Guidance of the LAA Closure Procedure: From Trans-Septal Puncture to Device Sizing and Placement

Atrial finbillation and LAA Closure in the MitraClip Patient

The case of Watchman Approval

Device-based LAA Closure 2014: From Indications to Worldwide Practice

LAA Closure: The Device, Attribute and Basic Technique- The Watchman Device -

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Watchman

Deep Dive of the Watchman Data: PROTECT AF, CAP AND PREVAIL Safety Issues

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Keynote Address: Interpreting PROTECT AF, CAP, and PREVAIL: Who Is the Ideal Patient?

Basic Echo Imaging of the LAA with Fluoroscopic Correlation

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Prevail Study: Design and Current Status

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content